Proposing a Coverage With Evidence Development Framework for Accelerated Approval at the U.S. Food and Drug Administration. [PDF]
Bearelly D +3 more
europepmc +1 more source
Survivorship Bias in the Shadows: A Methodological Concern Regarding Post-Transplant Survival Analysis in Pediatric VAD Recipients. [PDF]
Ishtiaq S, Malik ZM, Ahmad AR.
europepmc +1 more source
Beyond associations: Navigating the safety of non-steroidal anti-inflammatory drugs (NSAIDs) in early pregnancy. [PDF]
Yuen ASC, Man KKC.
europepmc +1 more source
Identifying the Initiation of a New Line of Therapy for Metastatic Lung, Breast, and Colorectal Cancer in Real-World Data: A Scoping Review. [PDF]
Onasanya O +19 more
europepmc +1 more source
Editorial: Utilizing real world data and real world evidence in veterinary medicine: current practices and future potentials. [PDF]
Wright A, Mwacalimba K, Rai T.
europepmc +1 more source
Trends in Medicines Discontinuation and Implications for Access in Brazil (2014-2024). [PDF]
de Lima ROM +6 more
europepmc +1 more source
Drug exposure definitions reported in real-world evidence studies on oncology medicines in patients with colorectal cancer: a scoping review. [PDF]
van Dommelen JEM +3 more
europepmc +1 more source
French Consumption of Methylphenidate in Primary Care From 2016 to 2023, Impact of Prescribing Policy Changes-A Time-Series Analysis. [PDF]
Saudreau C, Tarazona V, De Bandt D.
europepmc +1 more source
Implications of Medicare Negotiation and Most-Favored-Nation Pricing for Cancer Medicine Costs.
Hwang TJ +3 more
europepmc +1 more source
Suitability of Japanese Medical Databases for Studies on Infant Outcomes After Maternal Drug Exposure: An Evaluation Based on Core Data Elements. [PDF]
Hatakeyama S +8 more
europepmc +1 more source

